The Affiliated People's Hospital Of Ningbo University
Clinical trials sponsored by The Affiliated People's Hospital Of Ningbo University, explained in plain language.
-
Can a reduced-intensity drug combo tame high-risk myeloma in frail older patients?
Disease control Not yet recruitingThis trial tests whether a combination of isatuximab plus a reduced-intensity version of standard chemotherapy (VRDlite) can effectively treat newly diagnosed multiple myeloma in frail older adults who are not candidates for a stem cell transplant. The study focuses on patients w…
Phase: PHASE2, PHASE3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug aims to stop deadly complication in leukemia therapy
Prevention Not yet recruitingThis study tests whether the drug Lisaftoclax can prevent differentiation syndrome (DS), a severe and sometimes life-threatening side effect, in people with acute promyelocytic leukemia (APL) who are receiving standard treatment. About 60 participants aged 16 and older will take …
Phase: PHASE2, PHASE3 • Sponsor: The Affiliated People's Hospital of Ningbo University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC